Professor of Ophthalmology and Matrix Biology with research interests in the molecular basis of eye diseases and the development of novel therapeutics.
Honorary Consultant Ophthalmologist, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust
Paul is an ophthalmologist and clinician scientist. Soon after graduating in Medicine at Nottingham University he moved to Manchester. This is where he undertook his postgraduate medical training and he was appointed as an Honorary Consultant Ophthalmologist at Manchester Royal Eye Hospital in 1998. He specialises in the management of medical retinal conditions.
Whilst training as an ophthalmologist he completed a PhD in Biochemistry (1993). From 1991-2006 he held successive Wellcome Trust Clinical Fellowships including a Vision Research Training Fellowship, a Clinician Scientist Fellowship and a Senior Clinical Fellowship; he was appointed to a personal Chair in 2006.
His research spans from laboratory-based research through to clinical trials. Currently the main emphasis of his research is elucidating the molecular mechanisms underpinning age-related macular degeneration and developing new therapeutics for this condition. He also undertakes research into retinal dystrophies and has licensed to Acucela Inc. an optogenetic therapy which aims to restore vision in patients who are blind from these conditions.
B Med Sci Hons (University of Nottingham)
BM BS (University of Nottingham)
FRCS (London); FRCOphth
PhD (Biochemistry, University of Manchester)
CCT in Ophthalmology (Specialist Training Authority of the UK)
Chair of Academic Sub-Committee and Academic Lead, The Royal College of Opthalmologists1 Oct 2015
→ 1 Nov 2018
Chair of Research Committee, Macular Disease Society1 Sep 2011
→ 1 Jun 2018
Member of Steering Committee, UK Biobank Eye and Vision Consortium